和康生 (1783)
和康生 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$88.09M, up 35.3% from a year earlier. EPS over the last four quarters totals NT$3.25.
Company profile
Data as of 2026-10-18
- Market
- TWSE-listed
- Industry
- Biotech & Medical Care
- Listed
- 2013-12-20
- Founded
- 1998-12-03
- Paid-in capital
- NT$896.98M
- Common shares issued
- 89,698,115
- Legal name
- 和康生物科技股份有限公司
- Website
- https://www.mbi.com.tw
Monthly revenue
Data as of 2026-10-17
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$88.09M | +28.5% | +35.3% |
| 2026-08 | NT$68.53M | +7.5% | -2.5% |
Year to date: +7.7% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 0.88 |
| 2026 Q1 | 0.59 |
| 2025 Q4 | 0.94 |
| 2025 Q3 | 0.84 |
| 2025 Q2 | 0.65 |
| 2025 Q1 | 0.53 |
| 2024 Q4 | 0.58 |
| 2024 Q3 | 0.56 |
Last four quarters: NT$3.25
Dividends
Data as of 2026-10-18
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 2.00 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 33,950 | 0.3% |
| 1,000–5,000 shares | 2,988 | 6.4% |
| 5,001–10,000 shares | 475 | 3.9% |
| 10,001–15,000 shares | 200 | 2.7% |
| 15,001–20,000 shares | 82 | 1.6% |
| 20,001–30,000 shares | 83 | 2.2% |
| 30,001–40,000 shares | 49 | 1.9% |
| 40,001–50,000 shares | 25 | 1.3% |
| 50,001–100,000 shares | 63 | 4.8% |
| 100,001–200,000 shares | 33 | 5.1% |
| 200,001–400,000 shares | 18 | 5.3% |
| 400,001–600,000 shares | 8 | 4.0% |
| 600,001–800,000 shares | 3 | 2.4% |
| 800,001–1,000,000 shares | 2 | 2.0% |
| 1,000,001+ shares | 7 | 56.1% |
TDCC data for 2026-10-16: 7 holders own more than 1,000 lots (56.1% of shares), and 33,950 hold less than one lot (0.3%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | -9 | 0 | -1 | -10 |
| 2026-10-16 | 25 | 0 | 0 | 25 |
| 2026-10-15 | 17 | 0 | 0 | 17 |
| 2026-10-14 | 2 | 0 | 0 | 2 |
| 2026-10-13 | 2 | 0 | 4 | 6 |
| 2026-10-12 | -4 | 0 | 1 | -3 |
| 2026-10-08 | 6 | 0 | 0 | 6 |
| 2026-10-07 | -14 | 0 | 4 | -10 |
| 2026-10-06 | 38 | 0 | -2 | 36 |
| 2026-10-05 | -4 | 0 | 0 | -4 |
| 2026-10-02 | -1 | 0 | 0 | -1 |
| 2026-10-01 | 21 | 0 | 0 | 21 |
| 2026-09-30 | -1 | 0 | 1 | 0 |
| 2026-09-29 | -3 | 0 | 0 | -3 |
| 2026-09-24 | 4 | 0 | 0 | 4 |
| 2026-09-23 | 14 | 0 | 0 | 14 |
| 2026-09-22 | -2 | 0 | -23 | -25 |
| 2026-09-21 | 1 | 0 | -9 | -8 |
| 2026-09-18 | 35 | 0 | -9 | 26 |
| 2026-09-17 | 6 | 0 | -16 | -10 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 83 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$37.00 (2026-10-19); 52-week range NT$36.10–48.30.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.